Inherited ion channel diseases: a brief review

The Mechanism of Flecainide Action in CPVT Does Not Involve a Direct Effect on RyR2

(2015) M. L. Bannister et al.   CIRCULATION RESEARCH

Efficacy of Different Beta-Blockers in the Treatment of Long QT Syndrome

(2014) Abeer Abu-Zeitone et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Fever Increases the Risk for Cardiac Arrest in the Brugada Syndrome

(2013) Ahmad S. Amin et al.   ANNALS OF INTERNAL MEDICINE

Yield of Molecular and Clinical Testing for Arrhythmia Syndromes

(2013) Nynke Hofman et al.   CIRCULATION

Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes

(2013) Silvia G. Priori et al.   EUROPACE

Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death

(2013) Connie R Bezzina et al.   NATURE GENETICS

Mutations in Calmodulin Cause Ventricular Tachycardia and Sudden Cardiac Death

(2012) Mette Nyegaard et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Mutations in Cytoplasmic Loops of the KCNQ1 Channel and the Risk of Life-Threatening Events

(2012) Alon Barsheshet et al.   CIRCULATION

Seasonal and Circadian Distributions of Cardiac Events in Genotyped Patients With Congenital Long QT Syndrome

(2012) Masateru Takigawa et al.   CIRCULATION JOURNAL

Familial Evaluation in Catecholaminergic Polymorphic Ventricular Tachycardia

(2012) Christian van der Werf et al.   Circulation-Arrhythmia and Electrophysiology

Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human

(2012) Nathalie Roux-Buisson et al.   HUMAN MOLECULAR GENETICS

Spectrum and Prevalence of Mutations Involving BrS1- Through BrS12-Susceptibility Genes in a Cohort of Unrelated Patients Referred for Brugada Syndrome Genetic Testing

(2012) Lia Crotti et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Not All Beta-Blockers Are Equal in the Management of Long QT Syndrome Types 1 and 2

(2012) Priya Chockalingam et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardiac Channel Molecular Autopsy: Insights From 173 Consecutive Cases of Autopsy-Negative Sudden Unexplained Death Referred for Postmortem Genetic Testing

(2012) David J. Tester et al.   MAYO CLINIC PROCEEDINGS

QTc Behavior During Exercise and Genetic Testing for the Long-QT Syndrome

(2011) Peter J. Schwartz et al.   CIRCULATION

Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments

(2011) C. van der Werf et al.   EUROPACE

Electrophysiologic basis for the antiarrhythmic actions of ranolazine

(2011) Charles Antzelevitch et al.   HEART RHYTHM

Mutation and gender-specific risk in type 2 long QT syndrome: Implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome

(2011) Dimitry Migdalovich et al.   HEART RHYTHM

Electrophysiologic testing predicts events in Brugada syndrome patients

(2011) Josep Brugada et al.   HEART RHYTHM

Rebuttal to EP testing predicts cardiac events in patients with Brugada syndrome

(2011) Arthur A.M. Wilde et al.   HEART RHYTHM

Atrial remodeling in obstructive sleep apnea: Implications for atrial fibrillation

(2011) Hany Dimitri et al.   HEART RHYTHM

Flecainide Therapy Reduces Exercise-Induced Ventricular Arrhythmias in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia

(2011) Christian van der Werf et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome

(2010) V. Probst et al.   CIRCULATION

Short QT Syndrome: From Bench to Bedside

(2010) Chinmay Patel et al.   Circulation-Arrhythmia and Electrophysiology

Incidence and Risk Factors of Arrhythmic Events in Catecholaminergic Polymorphic Ventricular Tachycardia

(2009) Meiso Hayashi et al.   CIRCULATION

Prevalence of the Congenital Long-QT Syndrome

(2009) Peter J. Schwartz et al.   CIRCULATION

Drugs and Brugada syndrome patients: Review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org)

(2009) Pieter G. Postema et al.   HEART RHYTHM

An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing

(2009) Jamie D. Kapplinger et al.   HEART RHYTHM

Genotype-Phenotype Aspects of Type 2 Long QT Syndrome

(2009) Wataru Shimizu et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans

(2009) Hiroshi Watanabe et al.   NATURE MEDICINE

Fragmented QRS as a Marker of Conduction Abnormality and a Predictor of Prognosis of Brugada Syndrome

(2008) Hiroshi Morita et al.   CIRCULATION

Seasonal and circadian distributions of ventricular fibrillation in patients with Brugada syndrome

(2008) Masateru Takigawa et al.   HEART RHYTHM

Left Cardiac Sympathetic Denervation for Catecholaminergic Polymorphic Ventricular Tachycardia

(2008) Arthur A.M. Wilde et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cardiac Sodium Channel Overlap Syndromes: Different Faces of SCN5A Mutations

(2008) Carol Ann Remme et al.   TRENDS IN CARDIOVASCULAR MEDICINE